Salah Uddin Ahmed

This inventor holds 25 USPTO granted patents and 11 published patent applications and 5 EPO patents, primarily in Drug Delivery Systems. Top assignees: Teva Women's Health, Inc., Abon Pharmaceuticals LLC, Barr Laboratories, Inc.. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Salah Uddin Ahmed. Retrieved from https://idiyas.com/inventor/salah-uddin-ahmed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 25 (Patent Applications = 11)

% Patents Active = 60.0

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 253(Granted Patents)

Company Filing History:

9 out of 20

Teva Women's Health, Inc.

patents

8 out of 8

Abon Pharmaceuticals LLC

patents

3 out of 16

Barr Laboratories, Inc.

Teva Woman's Health, Inc.

patents

6. 1 out of 39

Watson Laboratories Inc.

patents

Years Active: 2001-2026

Loading Chart...

Areas of Expertise:

Transmucosal Delivery

Intravaginal Rings

Extended-Release Formulations

Orally Disintegrating Tablets

Progesterone Compositions

Vasomotor Symptoms Treatment

Solid Dosage Forms

Conjugated Estrogen Compositions

Mirtazapine Formulations

Clozapine Dosage Forms

Flexible Rings

Drug Delivery Methods

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12758547 - Long acting injectable formulations (2026-10-13),

2. 11801233 - Oral eliglustat transmucosal delivery system (2023-10-31),

3. 11596628 - Long acting injectable formulations (2023-03-07),

4. 11413294 - Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof (2022-08-16),

5. 11413271 - Oral eliglustat transmucosal delivery system (2022-08-16),

6. 10821118 - Oral transmucosal drug delivery system (2020-11-03),

7. 10548904 - Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof (2020-02-04),

8. 10537584 - Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof (2020-01-21),

9. 9795616 - Oral transmucosal drug delivery system (2017-10-24),

10. 9352047 - Oral transmucosal drug delivery system (2016-05-31),

11. 9011912 - Extended-release oral dosage forms for poorly soluble amine drugs (2015-04-21),

12. 8663681 - Oral dosage forms comprising progesterone and methods of making and using the same (2014-03-04),

13. 8580293 - Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof (2013-11-12),

14. 8323679 - Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same (2012-12-04),

15. 8288342 - Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate (2012-10-16),

Title: Inventor Salah Uddin Ahmed

Introduction: Salah Uddin Ahmed is a prolific inventor based in New City, NY, known for his groundbreaking contributions to various fields.

Latest Patents: Salah Uddin Ahmed holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Salah Uddin Ahmed has worked with leading research institutions and companies to develop innovative solutions that have had a significant impact on society.

Collaborations: Throughout his career, Salah Uddin Ahmed has collaborated with top scientists, engineers, and inventors, fostering a culture of creativity and excellence in his projects.

Conclusion: Salah Uddin Ahmed's dedication to innovation and his passion for creating a better future through his inventions make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.